{
    "2019-10-24": [
        [
            {
                "time": "2019-10-23",
                "original_text": "Eli Lilly and Company Reaffirms Buy (LLY)",
                "features": {
                    "keywords": [
                        "Reaffirms",
                        "Buy",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "Lilly Announces Cash Tender Offer for Up to $2.0 Billion Aggregate Principal Amount of Its Outstanding Debt Securities",
                "features": {
                    "keywords": [
                        "Cash Tender Offer",
                        "$2.0 Billion",
                        "Outstanding Debt Securities"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-23",
                "original_text": "The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",
                "features": {
                    "keywords": [
                        "Acorda",
                        "Trim Jobs",
                        "GlaxoSmithKline",
                        "FDA Nod",
                        "Edward Lifesciences",
                        "Q3 Beat-And-Raise"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}